Postcardiac transplant survival in the current era in patients receiving ... The Journal of Thoracic and Cardiovascular Surgery If the patient had renal dysfunction (glomerular filtration rate <30 mL/min/1.73 m2) for 3 days after transplantation, an interleukin-2 receptor antagonist was used (daclizumab was preferred until unavailable owing to product discontinuation, with ... |
